Member Article

Pharmanovia appoints Vice President of Product Innovation

Pharmanovia, the global lifecycle management company, has appointed Nivedita Valentine as Associate Vice President of Product Innovation.

Reporting to interim Chief Scientific Officer Stephen Deacon, Nivedita will oversee Pharmanovia’s product innovation operations and decision-making as Pharmanovia continues to focus efforts on both, identifying new prospects to enhance Lifecycle management of Pharmanovia’s well recognised brands through incremental innovation, and exciting novel therapies bridging unmet needs, originating both from in-house development and through partnerships.

Nivedita currently also holds positions on the value-added medicines committee within Medicines for Europe and the International Rare Diseases Research Consortium (IRDiRC) Task Force on Drug Repurposing Guidebook.

Nivedita brings more than fifteen years of leadership experience, deep market knowledge and technical expertise to Pharmanovia’s expanding product innovation division. She held global senior management positions overseeing Franchise Development and Business Development at Accord Healthcare and Glenmark Pharmaceuticals.

Pharmanovia CEO Dr James Burt commented: “Digitalisation and utilising the latest technological innovation are notable areas of acceleration within the pharma industry and Nivedita’s appointment will ensure iconic brands will continue to be improved, supported and used sustainably.

“I am delighted to welcome Nivedita to Pharmanovia as we continue the next phase of our strategic growth journey.”

Nivedita Valentine, Associate Vice President, Product Innovation at Pharmanovia said: “Pharmanovia is at an incredibly exciting point within its growth journey, rapidly establishing its position as a leader in lifecycle management with a strong, innovative pipeline. I’m excited to take on this role within such a committed, patient-centred organisation with an incredibly talented, like-minded team who constantly seek to identify new ways to enhance the lives of the patients.”

This was posted in Bdaily's Members' News section by Lucie Hayes .